Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 4/20 | 0.62 |
| ▸ | MME | P08473 | 4/20 | 0.62 |
| ▸ | CTSK | P43235 | 7/20 | 0.58 |
| ▸ | CTSB | P07858 | 4/20 | 0.55 |
| ▸ | ELANE | P08246 | 1/20 | 0.54 |
| ▸ | CTSL | P07711 | 3/20 | 0.54 |
| ▸ | CTSS | P25774 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9574224 | 1.00 | ECE1 (0.62) | ECE1MMECTSKCTSBELANE | |
| SCHEMBL7378851 | 0.90 | ECE1 (0.64) | ECE1MMECTSKCTSBCTSL | |
| SCHEMBL6272667 | 0.90 | ECE1 (0.64) | ECE1MMECTSKCTSBCTSL | |
| SCHEMBL8671882 | 0.90 | CTSL (0.63) | ECE1MMECTSKCTSBELANE | |
| SCHEMBL2978398 | 0.90 | CTSL (0.63) | ECE1MMECTSKCTSBELANE | |
| SCHEMBL220569 | 0.90 | CTSL (0.63) | ECE1MMECTSKCTSBELANE | |
| SCHEMBL1287168 | 0.90 | CTSL (0.63) | ECE1MMECTSKCTSBELANE | |
| SCHEMBL30748713 | 0.88 | CTSK (0.65) | CTSKCTSBELANECTSLCTSS | |
| SCHEMBL29576918 | 0.88 | CTSB (0.64) | ECE1MMECTSKCTSBCTSL | |
| SCHEMBL10980641 | 0.88 | CTSK (0.53) | ECE1MMECTSKCTSBELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3994148-A1 | PEPTIDE ACETALS FOR STABILISING ENZYMES | BASF SE (DE) | 2022-05-11 | — | — | EP | claimed |
| EP-4748846-A1 | METHOD FOR SYNTHESIZING AMIDE AND/OR POLYPEPTIDE BY TAKING TRANSIENTLY PROTECTED AMINO ACID AS AMMONIA COMPONENT | GUANGZHOU MEDICAL UNIVERSITY (CN) | 2026-05-27 | — | — | EP | disclosed |
| US-20260001907-A1 | Method for Synthesizing Amide and/or Polypeptide Using Transient Protected Amino Acid as Ammonia Component | UNIV GUANGZHOU MEDICAL (CN) | 2026-01-01 | — | — | US | disclosed |
| CN-119371478-A | Method for synthesizing amide and/or polypeptide by taking transient protection amino acid as ammonia component | 广州医科大学 | 2025-01-28 | — | — | CN | disclosed |
| WO-2025015659-A1 | METHOD FOR SYNTHESIZING AMIDE AND/OR POLYPEPTIDE BY TAKING TRANSIENTLY PROTECTED AMINO ACID AS AMMONIA COMPONENT | 广州医科大学 | 2025-01-23 | — | — | WO | disclosed |
| US-11946079-B2 | Method for producing a protein hydrolysate using an endopeptidase and a carboxypeptidase | NOVOZYMES A/S (DK) | 2024-04-02 | — | — | US | disclosed |
| US-20220127592-A1 | POLYPEPTIDE, USE AND METHOD FOR HYDROLYSING PROTEIN | NOVOZYMES A/S (DK) | 2022-04-28 | — | — | US | disclosed |
| EP-0321722-B1 | Process for obtaining dipeptides | DEGUSSA (DE) | 1994-02-16 | — | — | EP | disclosed |
| US-5216125-A | Active ester used for production of acylated amino acids | SANSHIN KAGAKU KOGYO CO. LTD. (JP) | 1993-06-01 | — | — | US | disclosed |
| US-5117031-A | ACTIVE ESTERS USED FOR PRODUCTION OF ESTERS OR AMIDES AND PROCESS FOR PRODUCING ESTERS OR AMIDES | SANSHIN KAGAKU KOGYO CO. LTD. (JP) | 1992-05-26 | — | — | US | disclosed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | disclosed |
| EP-0245662-B1 | P-HYDROXYPHENYLSULFONIUM SALTS AND THEIR USE IN THE PREPARATION OF ESTERS AND AMIDES | SANSHIN KAGAKU KOGYO CO., LTD. (JP) | 1991-08-07 | — | — | EP | disclosed |
| EP-0331988-A1 | Sulfonium compounds, as well as process for producing active esters and amides used for the production of amides | SANSHIN KAGAKU KOGYO CO., LTD. (JP) | 1989-09-13 | — | — | EP | disclosed |
| US-4857656-A | Active esters used for production of esters or amides and process for producing esters or amides | SANSHIN KAGAKU KOGYO CO., LTD. (JP) | 1989-08-15 | — | — | US | disclosed |
| EP-0321722-A2 | Process for obtaining dipeptides | Degussa Aktiengesellschaft (DE) | 1989-06-28 | — | — | EP | disclosed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0245662-A1 | p-Hydroxyphenylsulfonium salts and their use in the preparation of esters and amides | SANSHIN KAGAKU KOGYO CO., LTD. (JP) | 1987-11-19 | — | — | EP | disclosed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260001907-A1 | Method for Synthesizing Amide and/or Polypeptide Using Transient Protected Amino Acid as Ammonia Component | BCAT1, BCAT2, VIP | ECE1 2198/4885MME 1938/4885CTSK 842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.